2023-05-302024-05-312024-05-31false14903143Neurolink Therapies Ltd2025-02-2586900falseiso4217:GBPxbrli:pure149031432023-05-30149031432024-05-31149031432023-05-302024-05-31149031432023-05-29149031432023-05-29149031432023-05-292023-05-2914903143bus:SmallEntities2023-05-302024-05-3114903143bus:AuditExempt-NoAccountantsReport2023-05-302024-05-3114903143bus:AbridgedAccounts2023-05-302024-05-3114903143bus:PrivateLimitedCompanyLtd2023-05-302024-05-3114903143core:WithinOneYear2024-05-3114903143core:AfterOneYear2024-05-3114903143core:WithinOneYear2023-05-2914903143core:AfterOneYear2023-05-2914903143core:ShareCapital2024-05-3114903143core:SharePremium2024-05-3114903143core:RevaluationReserve2024-05-3114903143core:OtherReservesSubtotal2024-05-3114903143core:RetainedEarningsAccumulatedLosses2024-05-3114903143core:ShareCapital2023-05-2914903143core:SharePremium2023-05-2914903143core:RevaluationReserve2023-05-2914903143core:OtherReservesSubtotal2023-05-2914903143core:RetainedEarningsAccumulatedLosses2023-05-2914903143core:LandBuildings2024-05-3114903143core:PlantMachinery2024-05-3114903143core:Vehicles2024-05-3114903143core:FurnitureFittings2024-05-3114903143core:OfficeEquipment2024-05-3114903143core:NetGoodwill2024-05-3114903143core:IntangibleAssetsOtherThanGoodwill2024-05-3114903143core:ListedExchangeTraded2024-05-3114903143core:UnlistedNon-exchangeTraded2024-05-3114903143core:LandBuildings2023-05-2914903143core:PlantMachinery2023-05-2914903143core:Vehicles2023-05-2914903143core:FurnitureFittings2023-05-2914903143core:OfficeEquipment2023-05-2914903143core:NetGoodwill2023-05-2914903143core:IntangibleAssetsOtherThanGoodwill2023-05-2914903143core:ListedExchangeTraded2023-05-2914903143core:UnlistedNon-exchangeTraded2023-05-2914903143core:LandBuildings2023-05-302024-05-3114903143core:PlantMachinery2023-05-302024-05-3114903143core:Vehicles2023-05-302024-05-3114903143core:FurnitureFittings2023-05-302024-05-3114903143core:OfficeEquipment2023-05-302024-05-3114903143core:NetGoodwill2023-05-302024-05-3114903143core:IntangibleAssetsOtherThanGoodwill2023-05-302024-05-3114903143core:ListedExchangeTraded2023-05-302024-05-3114903143core:UnlistedNon-exchangeTraded2023-05-302024-05-3114903143core:MoreThanFiveYears2023-05-302024-05-3114903143core:Non-currentFinancialInstruments2024-05-3114903143core:Non-currentFinancialInstruments2023-05-2914903143dpl:CostSales2023-05-302024-05-3114903143dpl:DistributionCosts2023-05-302024-05-3114903143core:LandBuildings2023-05-302024-05-3114903143core:PlantMachinery2023-05-302024-05-3114903143core:Vehicles2023-05-302024-05-3114903143core:FurnitureFittings2023-05-302024-05-3114903143core:OfficeEquipment2023-05-302024-05-3114903143dpl:AdministrativeExpenses2023-05-302024-05-3114903143core:NetGoodwill2023-05-302024-05-3114903143core:IntangibleAssetsOtherThanGoodwill2023-05-302024-05-3114903143dpl:GroupUndertakings2023-05-302024-05-3114903143dpl:ParticipatingInterests2023-05-302024-05-3114903143dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-302024-05-3114903143core:ListedExchangeTraded2023-05-302024-05-3114903143dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-302024-05-3114903143core:UnlistedNon-exchangeTraded2023-05-302024-05-3114903143dpl:CostSales2023-05-292023-05-2914903143dpl:DistributionCosts2023-05-292023-05-2914903143core:LandBuildings2023-05-292023-05-2914903143core:PlantMachinery2023-05-292023-05-2914903143core:Vehicles2023-05-292023-05-2914903143core:FurnitureFittings2023-05-292023-05-2914903143core:OfficeEquipment2023-05-292023-05-2914903143dpl:AdministrativeExpenses2023-05-292023-05-2914903143core:NetGoodwill2023-05-292023-05-2914903143core:IntangibleAssetsOtherThanGoodwill2023-05-292023-05-2914903143dpl:GroupUndertakings2023-05-292023-05-2914903143dpl:ParticipatingInterests2023-05-292023-05-2914903143dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-292023-05-2914903143core:ListedExchangeTraded2023-05-292023-05-2914903143dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-292023-05-2914903143core:UnlistedNon-exchangeTraded2023-05-292023-05-2914903143core:NetGoodwill2024-05-3114903143core:IntangibleAssetsOtherThanGoodwill2024-05-3114903143core:LandBuildings2024-05-3114903143core:PlantMachinery2024-05-3114903143core:Vehicles2024-05-3114903143core:FurnitureFittings2024-05-3114903143core:OfficeEquipment2024-05-3114903143core:AfterOneYear2024-05-3114903143core:WithinOneYear2024-05-3114903143core:ListedExchangeTraded2024-05-3114903143core:UnlistedNon-exchangeTraded2024-05-3114903143core:ShareCapital2024-05-3114903143core:SharePremium2024-05-3114903143core:RevaluationReserve2024-05-3114903143core:OtherReservesSubtotal2024-05-3114903143core:RetainedEarningsAccumulatedLosses2024-05-3114903143core:NetGoodwill2023-05-2914903143core:IntangibleAssetsOtherThanGoodwill2023-05-2914903143core:LandBuildings2023-05-2914903143core:PlantMachinery2023-05-2914903143core:Vehicles2023-05-2914903143core:FurnitureFittings2023-05-2914903143core:OfficeEquipment2023-05-2914903143core:AfterOneYear2023-05-2914903143core:WithinOneYear2023-05-2914903143core:ListedExchangeTraded2023-05-2914903143core:UnlistedNon-exchangeTraded2023-05-2914903143core:ShareCapital2023-05-2914903143core:SharePremium2023-05-2914903143core:RevaluationReserve2023-05-2914903143core:OtherReservesSubtotal2023-05-2914903143core:RetainedEarningsAccumulatedLosses2023-05-2914903143core:NetGoodwill2023-05-2914903143core:IntangibleAssetsOtherThanGoodwill2023-05-2914903143core:LandBuildings2023-05-2914903143core:PlantMachinery2023-05-2914903143core:Vehicles2023-05-2914903143core:FurnitureFittings2023-05-2914903143core:OfficeEquipment2023-05-2914903143core:AfterOneYear2023-05-2914903143core:WithinOneYear2023-05-2914903143core:ListedExchangeTraded2023-05-2914903143core:UnlistedNon-exchangeTraded2023-05-2914903143core:ShareCapital2023-05-2914903143core:SharePremium2023-05-2914903143core:RevaluationReserve2023-05-2914903143core:OtherReservesSubtotal2023-05-2914903143core:RetainedEarningsAccumulatedLosses2023-05-2914903143core:AfterOneYear2023-05-302024-05-3114903143core:WithinOneYear2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:CostValuation2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-302024-05-3114903143core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3114903143core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3114903143core:Non-currentFinancialInstrumentscore:CostValuation2023-05-2914903143core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-2914903143core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-2914903143bus:Director12023-05-302024-05-3114903143bus:Director22023-05-302024-05-31

Neurolink Therapies Ltd

Registered Number
14903143
(England and Wales)

Unaudited Financial Statements for the Period ended
31 May 2024

Neurolink Therapies Ltd
Company Information
for the period from 30 May 2023 to 31 May 2024

Directors

Mr SC Emery
Mrs N Nathu

Company Secretary

Mr M Kholia

Registered Address

37 Deeming Drive
Quorn
Loughborough
LE12 8NF

Registered Number

14903143 (England and Wales)
Neurolink Therapies Ltd
Balance Sheet as at
31 May 2024

Notes

2024

£

£

Fixed assets
Tangible assets3475
475
Current assets
Debtors472,113
Cash at bank and on hand17,844
89,957
Creditors amounts falling due within one year5(70,213)
Net current assets (liabilities)19,744
Total assets less current liabilities20,219
Net assets20,219
Capital and reserves
Called up share capital2
Profit and loss account20,217
Shareholders' funds20,219
The financial statements were approved and authorised for issue by the Board of Directors on 25 February 2025, and are signed on its behalf by:
Mr SC Emery
Director
Mrs N Nathu
Director

Registered Company No. 14903143
Neurolink Therapies Ltd
Notes to the Financial Statements
for the period ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Functional and presentation currency
The presentation currency of the financial statements is the Pound Sterling (£).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Tangible fixed assets and depreciation
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Straight line (years)
Office Equipment4
Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities. Financial assets are measured at amortised cost and comprise of cash and cash equivalents and trade and other debtors. Financial liabilities are measured at amortised cost and comprise of trade and other creditors.
2.Average number of employees

2024
Average number of employees during the year0
3.Tangible fixed assets

Total

£
Cost or valuation
Additions600
At 31 May 24600
Depreciation and impairment
Charge for year125
At 31 May 24125
Net book value
At 31 May 24475
At 29 May 23-
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables46,425
Prepayments and accrued income25,688
Total72,113
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables14,548
Taxation and social security8,379
Other creditors19,611
Accrued liabilities and deferred income27,675
Total70,213